6/16/2010

Pathwork Diagnostics has received FDA clearance for its tissue-of-origin test, which can be used on clinical formalin-fixed, paraffin-embedded tumor samples. The cancer test uses Affymetrix's microarray technology to examine the expression levels of about 2,000 genes.

Related Summaries